Metabolic acidosis: pathophysiology, diagnosis and management
@article{Kraut2010MetabolicAP, title={Metabolic acidosis: pathophysiology, diagnosis and management}, author={Jeffrey A Kraut and Nicolaos E Madias}, journal={Nature Reviews Nephrology}, year={2010}, volume={6}, pages={274-285} }
Metabolic acidosis is characterized by a primary reduction in serum bicarbonate (HCO3−) concentration, a secondary decrease in the arterial partial pressure of carbon dioxide (PaCO2) of ∼1 mmHg for every 1 mmol/l fall in serum HCO3− concentration, and a reduction in blood pH. Acute forms (lasting minutes to several days) and chronic forms (lasting weeks to years) of the disorder can occur, for which the underlying cause/s and resulting adverse effects may differ. Acute forms of metabolic…
217 Citations
Metabolic Acidosis and Chronic Kidney Disease
- Medicine, Biology
- 2014
Treatment with base in the form of Shohl’s solution, sodium bicarbonate, or increased amounts of fruits and vegetables can all be successful in raising serum biccarbonate concentration, but it is recommended it be raised close to or at the normal level of 24 mmol/L.
Treatment of acute metabolic acidosis: a pathophysiologic approach
- Medicine, BiologyNature Reviews Nephrology
- 2012
Given the important effects of acute metabolic acidosis on clinical outcomes, more intensive study of the pathogenesis of the associated cellular dysfunction and novel methods of treatment is indicated.
Metabolic Acidosis and Cardiovascular Disease
- Biology, Medicine
- 2016
The chapter reviews available information on the impact of acute and chronic metabolic acidosis on cardiovascular function, the possible underlying mechanisms, and theimpact of base therapy.
Pharmacologically-Induced Metabolic Acidosis
- Medicine, BiologyDrug safety
- 2010
Determinations of arterial blood gases, the serum anion gap and the serum osmolar gap are helpful in delineating the pathogenesis of the acid-base disorder, and in all cases of drug-related metabolic acidosis, discontinuation of the culprit medications and avoidance of readministration is advised.
Pathophysiologic Approach to Metabolic Acidosis
- Medicine, Biology
- 2016
Deviations from the presumed 1:1 ratio in this relationship that is present in a high AG metabolic acidosis can be used to diagnose complex mixed acid–base disorders.
The Use and Interpretation of Serum Bicarbonate Concentration in Dialysis Patients
- Medicine, BiologySeminars in dialysis
- 2014
The genesis of the metabolic acidosis of CKD, the value and limitations of the parameters used to assess its course, the factors affecting its onset and severity, its impact on cellular function and clinical outcome, and the level of acid–base parameters that should be achieved to ensure the best clinical outcomes are summarized.
Acid-Base Disorders
- MedicineClinical Algorithms in General Surgery
- 2019
Treatment of acid-base disturbances focuses on correcting the underlying pathophysiology and may include vasopressor support, blood transfusion, renal replacement therapy, ventilator adjustment, and antibiotics when necessary.
The Janus faces of bicarbonate therapy in the ICU
- Medicine, BiologyIntensive Care Medicine
- 2019
Facing metabolic acidemia, a short list of strong indications (gastrointestinal or urinary loss of bases, ethylene glycol, methanol and salicylate poisoning) and non-indications (diabetic ketoacidosis, tumor lysis syndrome) have been recommended.
Buffer Therapy in Acute Metabolic Acidosis: Effects on Acid-Base Status and Glomerular Permeability
- Medicine, Biology
- 2019
These data demonstrate a remarkable tolerance of the glomerular filter to severe acute acidosis and bicarbonate therapy, and cast light on the buffer mechanism in erythrocytes and the ability of different acid-base parameters to evaluate the extent of an acid- base disorder.
Non-Anion Gap Metabolic Acidosis: A Clinical Approach to Evaluation.
- MedicineAmerican journal of kidney diseases : the official journal of the National Kidney Foundation
- 2017
The present case was selected to highlight the differential diagnosis of a non-anion gap metabolic acidosis and illustrate a systematic approach to this problem.
References
SHOWING 1-10 OF 146 REFERENCES
Acute metabolic acidosis: characterization and diagnosis of the disorder and the plasma potassium response.
- Medicine, BiologyJournal of the American Society of Nephrology : JASN
- 2004
The finding of a hyperinsulinemic response in acute metabolic acidosis suggests that an insulin response counterregulates any acidemia-induced cellular potassium efflux, resulting in stable plasma potassium concentrations.
Metabolic acidosis of CKD: diagnosis, clinical characteristics, and treatment.
- Medicine, BiologyAmerican journal of kidney diseases : the official journal of the National Kidney Foundation
- 2005
Whether normalization of plasma bicarbonate concentrations in all patients is desirable therefore requires additional study, but benefits and complications of therapy are addressed, and potential adverse effects are discussed.
Increased anion gap metabolic acidosis as a result of 5-oxoproline (pyroglutamic acid): a role for acetaminophen.
- MedicineClinical journal of the American Society of Nephrology : CJASN
- 2006
The chronic ingestion of acetaminophen, especially by malnourished women, may generate high anion gap metabolic acidosis, and this undoubtedly is an underdiagnosed condition because measurements of serum and/or urinary 5-oxoproline levels are not readily available.
Recurrent high anion gap metabolic acidosis secondary to 5-oxoproline (pyroglutamic acid).
- MedicineAmerican journal of kidney diseases : the official journal of the National Kidney Foundation
- 2005
Suspicion for 5-oxoproline-associated high anion gap metabolic acidosis in a 48-year-old man who initially presented with anorexia and malaise should be entertained when the cause of high anionspheric acidosis remains poorly defined, the aniongap cannot be explained reasonably by measured organic acids, and there is concomitant acetaminophen use.
Metabolic and clinical consequences of metabolic acidosis.
- Medicine, BiologyJournal of nephrology
- 2006
To avoid abnormalities in metabolism and the loss of bone and muscle, metabolic acidosis must be corrected in normal adults and in patients with kidney disease.
Clinical significance of the fractional excretion of anions in metabolic acidosis.
- Medicine, BiologyClinical nephrology
- 2001
The fractional excretion of anions has been proposed as a new index for the differential diagnosis of metabolic acidosis, identifying the properties of the conjugate base by examining the renal…
Changes in the plasma anion gap during chronic metabolic acid-base disturbances.
- Biology, MedicineThe American journal of physiology
- 1978
The data indicate that the plasma anion gap decreases significantly in HCl acidosis and increases significantly in metabolic alkalosis; the predicted meanAnion gap in animals with a plasma bicarbonate concentration of 10, 21, and 40 meq/liter approximated 13, 18, and 26 meq /liter, respectively.
Hypochloremia as a consequence of anion gap metabolic acidosis.
- Medicine, BiologyThe Journal of laboratory and clinical medicine
- 1984
Three forms of anion gap acidosis are studied in unanesthetized, nephrectomized rats to examine the possibility that an element of hypochloremia might, under certain circumstances, be an integral part of the underlying acidosis.
Correction of metabolic acidosis improves thyroid and growth hormone axes in haemodialysis patients.
- Medicine, BiologyNephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association
- 2004
Correcting chronic haemodialysis patients with daily oral Na-citrate may improve nutritional and metabolic parameters and thus lower morbidity and mortality, as well as modulator of systemic inflammation in dialysis patients.
Correction of chronic metabolic acidosis for chronic kidney disease patients.
- Medicine, BiologyThe Cochrane database of systematic reviews
- 2007
The evidence for the benefits and risks of correcting metabolic acidosis is very limited with no RCTs in pre-ESRD patients, none in children, and only three small trials in dialysis patients, which suggest there may be some beneficial effects on both protein and bone metabolism.